Dr. Arthur H. Tinkelenberg, PhD is former President and Chief Executive Officer of Enumeral Biomedical Corporation. Dr. Tinkelenberg previously served as a Partner of Ascent BioMedical Ventures (ABV). Prior to joining ABV, Dr. Tinkelenberg worked in the Healthcare Investment Banking and Mergers and Acquisitions Groups at Robertson Stephens. He has served as a Director of a number of companies, and is currently an Advisor to Torreya, a strategic advisory firm focused on the biotechnology and pharmaceutical sectors. Dr. Tinkelenberg earned his Ph.D. degree in Molecular Genetics from The Rockefeller University where he studied cell growth regulation and signal transduction as a Rockefeller and National Science Foundation Fellow and earned his BA degree in Biology, with honors, from Grinnell College.